Lennox International Inc. (LII) Stock Forecast
Data as of Oct 31, 2026Industrials · Current price $341.85 (-1.80%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 29, 2026 | Deane Dray | RBC Capital | $534.00 | +56.2% |
| Jan 15, 2026 | Deane Dray | RBC Capital | $563.00 | +64.7% |
| Jan 7, 2026 | Julian Mitchell | Barclays | $667.00 | +95.1% |
| Dec 11, 2025 | Julian Mitchell | Barclays | $680.00 | +98.9% |
| Dec 4, 2025 | Joseph O'Dea | Wells Fargo | $525.00 | +53.6% |
| Oct 27, 2025 | Damian Karas | UBS | $560.00 | +63.8% |
| Oct 27, 2025 | Aaron Reed | Northcoast Research | $525.00 | +53.6% |
| Oct 23, 2025 | Joseph O'Dea | Wells Fargo | $545.00 | +59.4% |
| Oct 23, 2025 | Christopher Snyder | Morgan Stanley | $475.00 | +38.9% |
| Oct 6, 2025 | Joseph O'Dea | Wells Fargo | $575.00 | +68.2% |
| Jul 28, 2025 | Damian Karas | UBS | $676.00 | +97.7% |
| Apr 24, 2025 | Noah Kaye | Oppenheimer | $600.00 | +75.5% |
| Feb 3, 2025 | Joseph O'Dea | Wells Fargo | $580.00 | +69.7% |
| Oct 24, 2024 | Brett Linzey | Mizuho Securities | $675.00 | +97.5% |
| Oct 24, 2024 | Deane Dray | RBC Capital | $619.00 | +81.1% |
| Oct 24, 2024 | Julian Mitchell | Barclays | $624.00 | +82.5% |
| Oct 15, 2024 | Jeffrey Hammond | KeyBanc | $600.00 | +75.5% |
| Oct 14, 2024 | Timothy Wojs | Robert W. Baird | $648.00 | +89.6% |
| Jul 15, 2024 | Timothy Wojs | Robert W. Baird | $610.00 | +78.4% |
| Jul 9, 2024 | Joseph O'Dea | Wells Fargo | $570.00 | +66.7% |
Top Analysts Covering LII
LII vs Sector & Market
| Metric | LII | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.40 | 2.41 |
| Analyst Count | 11 | 8 | 19 |
| Target Upside | +29.0% | +134.2% | +21.5% |
| P/E Ratio | 15.38 | 31.65 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.37B | $5.49B | $5.58B | 17 |
| 2027-03-31 | $1.08B | $1.12B | $1.15B | 7 |
| 2027-06-30 | $1.58B | $1.64B | $1.69B | 7 |
| 2027-09-30 | $1.57B | $1.63B | $1.69B | 7 |
| 2027-12-31 | $1.33B | $1.38B | $1.43B | 7 |
| 2028-03-31 | $1.14B | $1.19B | $1.23B | 6 |
| 2028-06-30 | $1.14B | $1.19B | $1.23B | 6 |
| 2028-09-30 | $1.14B | $1.18B | $1.22B | 6 |
| 2028-12-31 | $1.14B | $1.18B | $1.22B | 6 |
| 2029-12-31 | $6.12B | $6.30B | $6.52B | 5 |
| 2030-12-31 | $6.82B | $7.02B | $7.27B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $22.85 | $24.12 | $26.15 | 15 |
| 2027-03-31 | $3.34 | $3.50 | $3.65 | 10 |
| 2027-06-30 | $7.87 | $8.25 | $8.61 | 7 |
| 2027-09-30 | $7.98 | $8.37 | $8.73 | 7 |
| 2027-12-31 | $5.71 | $5.98 | $6.24 | 14 |
| 2028-03-31 | $3.84 | $4.02 | $4.20 | 11 |
| 2028-06-30 | $8.58 | $9.00 | $9.39 | 8 |
| 2028-09-30 | $9.07 | $9.51 | $9.92 | 8 |
| 2028-12-31 | $6.12 | $6.42 | $6.70 | 15 |
| 2029-12-31 | $29.36 | $30.49 | $31.89 | 2 |
| 2030-12-31 | $35.56 | $36.93 | $38.62 | 2 |
Frequently Asked Questions
What is the analyst consensus for LII?
The consensus among 11 analysts covering Lennox International Inc. (LII) is Hold with an average price target of $529.67.
What is the highest price target for LII?
The highest price target for LII is $680.00, set by Julian Mitchell at Barclays on 2025-12-11.
What is the lowest price target for LII?
The lowest price target for LII is $238.00, set by Joshua Pokrzywinski at Morgan Stanley on 2022-06-07.
How many analysts cover LII?
11 analysts have issued ratings for Lennox International Inc. in the past 12 months.
Is LII a buy or sell right now?
Based on 11 analyst ratings, LII has a consensus rating of Hold (3.00/5) with a +29.0% upside to the consensus target of $529.67.
What are the earnings estimates for LII?
Analysts estimate LII will report EPS of $24.12 for the period ending 2026-12-31, with revenue estimated at $5.49B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.